Yellow astringent and Obstructive uropathy - from FDA reports
Summary
There is no Obstructive uropathy reported by people who take Yellow astringent yet. This review analyzes which people have Obstructive uropathy with Yellow astringent. It is created by eHealthMe based on reports from FDA, and is updated regularly.
What to expect?
Personalized health information
On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA since 1977. Our tools are simple to use, anonymous and free. Start now >>>
On Jul, 11, 2017
No report is found.
How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.
Do you have Obstructive uropathy when taking Yellow astringent?
- Check symptoms - is obstructive uropathy caused by a drug or a condition?
- Get alerts to symptoms - forecast your symptoms and get alerts
- Report the side effect - help people in need and in real time
- More tools...
Yellow Astringent
Yellow astringent has active ingredients of ephedra.
Obstructive Uropathy
Obstructive uropathy (a blockage that prevents urine from leaving your kidneys) has been reported by people with multiple sclerosis, prostate cancer, high blood pressure, osteoporosis, kidney transplant (latest reports from 1,827 Obstructive uropathy patients).
